image
Arbutus Biopharma Corporation ABUS
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 3.21
1.9 %
$ 608 M
Market Cap
-8.45
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
130.28%
EBIT Estimate
--22.80%
Net Income Estimate
30.53%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Arbutus Biopharma Corporation
image
ABUS has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart ABUS

image
$180.0m$180.0m$160.0m$160.0m$140.0m$140.0m$120.0m$120.0m$100.0m$100.0m$80.0m$80.0m$60.0m$60.0m$40.0m$40.0m$20.0m$20.0m$0.0$0.0201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart ABUS

image
$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)($250.0m)($250.0m)($300.0m)($300.0m)($350.0m)($350.0m)($400.0m)($400.0m)($450.0m)($450.0m)($500.0m)($500.0m)201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart ABUS

image
$100.0m$100.0m$0.0$0.0($100.0m)($100.0m)($200.0m)($200.0m)($300.0m)($300.0m)($400.0m)($400.0m)($500.0m)($500.0m)($600.0m)($600.0m)($700.0m)($700.0m)($800.0m)($800.0m)201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029